Answers are grounded in this paper and cite their sources.
Reviews mechanisms and therapeutic options in noncardiac chest pain, highlighting the efficacy of antireflux therapy and pain modulators over invasive interventions.
Noncardiac chest pain (NCCP) affects approximately 1 quarter of the adult population in the United States. The pathophysiology of the disorder remains to be fully elucidated. Identified underlying mechanisms for esophageal pain include gastroesophageal reflux disease (GERD), esophageal dysmotility, and visceral hypersensitivity. Aggressive antireflux treatment has been the main therapeutic strategy for GERD-related NCCP. NCCP patients with or without spastic esophageal motor disorders are responsive to pain modulators. The value of botulinum toxin injection, endoscopic treatment for GERD, and antireflux surgery in alleviating NCCP symptoms is limited.
No takes yet. Share an insight, caveat, or question.
Fass et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: